Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. Proton-coupled amino acid transporter 2
Proton-coupled amino acid transporter 2
From Wikipedia, the free encyclopedia
(Redirected from SLC36A2)
Protein-coding gene in the species Homo sapiens
SLC36A2
Identifiers
AliasesSLC36A2, PAT2, TRAMD1, solute carrier family 36 member 2
External IDsOMIM: 608331; MGI: 1891430; HomoloGene: 72100; GeneCards: SLC36A2; OMA:SLC36A2 - orthologs
Gene location (Human)
Chromosome 5 (human)
Chr.Chromosome 5 (human)[1]
Chromosome 5 (human)
Genomic location for SLC36A2
Genomic location for SLC36A2
Band5q33.1Start151,314,972 bp[1]
End151,347,590 bp[1]
Gene location (Mouse)
Chromosome 11 (mouse)
Chr.Chromosome 11 (mouse)[2]
Chromosome 11 (mouse)
Genomic location for SLC36A2
Genomic location for SLC36A2
Band11|11 B1.3Start55,049,296 bp[2]
End55,075,903 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • quadriceps femoris muscle

  • skeletal muscle tissue

  • gastrocnemius muscle

  • muscle of thigh

  • human kidney

  • tibial nerve

  • testicle

  • sural nerve

  • gonad

  • renal cortex
Top expressed in
  • brown adipose tissue

  • sciatic nerve

  • body of femur

  • subcutaneous adipose tissue

  • mammary gland

  • intercostal muscle

  • white adipose tissue

  • humerus

  • aorta

  • otolith organ
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
  • L-alanine transmembrane transporter activity
  • amino acid:proton symporter activity
  • L-proline transmembrane transporter activity
  • glycine transmembrane transporter activity
  • proton transmembrane transporter activity
  • amino acid transmembrane transporter activity
Cellular component
  • cytoplasm
  • integral component of membrane
  • plasma membrane
  • extracellular exosome
  • membrane
  • vacuolar membrane
Biological process
  • proline transmembrane transport
  • ion transport
  • amino acid transport
  • glycine transport
  • L-alanine transport
  • proline transport
  • proton transmembrane transport
  • transport
  • amino acid transmembrane transport
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

153201

246049

Ensembl

ENSG00000186335

ENSMUSG00000020264

UniProt

Q495M3

Q8BHK3

RefSeq (mRNA)

NM_181776

NM_153170

RefSeq (protein)

NP_861441

NP_694810

Location (UCSC)Chr 5: 151.31 – 151.35 MbChr 11: 55.05 – 55.08 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Proton-coupled amino acid transporter 2 is a protein which in humans is encoded by the SLC36A2 gene.[5]

Function

[edit]

SLC36A2 transports small amino acids (glycine, alanine, and proline) and also the D-enantiomers and select amino acid derivatives, such as gamma-aminobutyric acid.[5][6]

Clinical significance

[edit]

Mutations in the SLC36A2 gene are associated with Iminoglycinuria.[7]

See also

[edit]
  • Proton coupled amino acid transporter

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000186335 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000020264 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b Boll M, Foltz M, Rubio-Aliaga I, Daniel H (July 2003). "A cluster of proton/amino acid transporter genes in the human and mouse genomes". Genomics. 82 (1): 47–56. doi:10.1016/S0888-7543(03)00099-5. PMID 12809675.
  6. ^ Boll M, Foltz M, Rubio-Aliaga I, Kottra G, Daniel H (June 2002). "Functional characterization of two novel mammalian electrogenic proton-dependent amino acid cotransporters". J. Biol. Chem. 277 (25): 22966–73. doi:10.1074/jbc.M200374200. PMID 11959859.
  7. ^ Bröer S, Bailey CG, Kowalczuk S, Ng C, Vanslambrouck JM, Rodgers H, Auray-Blais C, Cavanaugh JA, Bröer A, Rasko JE (December 2008). "Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters". J. Clin. Invest. 118 (12): 3881–92. doi:10.1172/JCI36625. PMC 2579706. PMID 19033659.

Further reading

[edit]
  • Bermingham JR, Pennington J (2004). "Organization and expression of the SLC36 cluster of amino acid transporter genes". Mamm. Genome. 15 (2): 114–25. doi:10.1007/s00335-003-2319-3. PMID 15058382. S2CID 21418124.
  • Trynka G, Zhernakova A, Romanos J, et al. (2009). "Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling". Gut. 58 (8): 1078–83. doi:10.1136/gut.2008.169052. PMID 19240061. S2CID 17111427.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Bröer S (2008). "Amino acid transport across mammalian intestinal and renal epithelia". Physiol. Rev. 88 (1): 249–86. doi:10.1152/physrev.00018.2006. PMID 18195088.
  • Koskinen LL, Einarsdottir E, Korponay-Szabo IR, et al. (2009). "Fine mapping of the CELIAC2 locus on chromosome 5q31-q33 in the Finnish and Hungarian populations". Tissue Antigens. 74 (5): 408–16. doi:10.1111/j.1399-0039.2009.01359.x. PMID 19845895.
  • Rubio-Aliaga I, Boll M, Vogt Weisenhorn DM, et al. (2004). "The proton/amino acid cotransporter PAT2 is expressed in neurons with a different subcellular localization than its paralog PAT1". J. Biol. Chem. 279 (4): 2754–60. doi:10.1074/jbc.M305556200. PMID 14600155.
  • v
  • t
  • e
Membrane proteins, carrier proteins: membrane transport proteins solute carrier (TC 2A)
By group
SLC1–10
(1):
  • high affinity glutamate and neutral amino-acid transporter
    • SLC1A1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
(2):
  • facilitative GLUT transporter
    • SLC2A1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
(3):
  • heavy subunits of heterodimeric amino-acid transporters
    • SLC3A1
    • 2
(4):
  • bicarbonate transporter
    • SLC4A1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
(5):
  • sodium glucose cotransporter
    • SLC5A1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
(6):
  • sodium- and chloride- dependent sodium:neurotransmitter symporters
    • SLC6A1
    • SLC6A2
    • SLC6A3
    • SLC6A4
    • SLC6A5
    • SLC6A6
    • SLC6A7
    • SLC6A8
    • SLC6A9
    • SLC6A10
    • SLC6A11
    • SLC6A12
    • SLC6A13
    • SLC6A14
    • SLC6A15
    • SLC6A16
    • SLC6A17
    • SLC6A18
    • SLC6A19
    • SLC6A20
(7):
  • cationic amino-acid transporter/glycoprotein-associated
    • SLC7A1
    • SLC7A2
    • SLC7A3
    • SLC7A4
  • glycoprotein-associated/light or catalytic subunits of heterodimeric amino-acid transporters
    • SLC7A5
    • SLC7A6
    • SLC7A7
    • SLC7A8
    • SLC7A9
    • SLC7A10
    • SLC7A11
    • SLC7A13
    • SLC7A14
(8):
  • Na+/Ca2+ exchanger
    • SLC8A1
    • SLC8A2
    • SLC8A3
(9):
  • Na+/H+ exchanger
    • SLC9A1
    • SLC9A2
    • SLC9A3
    • SLC9A4
    • SLC9A5
    • SLC9A6
    • SLC9A7
    • SLC9A8
    • SLC9A9
    • SLC9A10
    • SLC9A11
(10):
  • sodium bile salt cotransport
    • SLC10A1
    • SLC10A2
    • SLC10A3
    • SLC10A4
    • SLC10A5
    • SLC10A6
    • SLC10A7
  • 10A1
  • 10A2
  • 10A3
  • 10A7
SLC11–20
(11):
  • proton coupled metal ion transporter
    • SLC11A1
    • SLC11A211A3
(12):
  • electroneutral cation-Cl cotransporter
    • SLC12A1
    • SLC12A2
    • SLC12A3
    • SLC12A4
    • SLC12A5
    • SLC12A6
    • SLC12A7
    • SLC12A8
    • SLC12A9
(13):
  • human Na+-sulfate/carboxylate cotransporter
    • SLC13A1
    • SLC13A2
    • SLC13A3
    • SLC13A4
    • SLC13A5
(14):
  • urea transporter
    • SLC14A1
    • SLC14A2
(15):
  • proton oligopeptide cotransporter
    • SLC15A1
    • SLC15A2
    • SLC15A3
    • SLC15A4
(16):
  • monocarboxylate transporter
    • SLC16A1
    • SLC16A2
    • SLC16A3
    • SLC16A4
    • SLC16A5
    • SLC16A6
    • SLC16A7
    • SLC16A8
    • SLC16A9
    • SLC16A10
    • SLC16A11
    • SLC16A12
    • SLC16A13
    • SLC16A14
(17):
  • Vesicular glutamate transporter 1
    • SLC17A1
    • SLC17A2
    • SLC17A3
    • SLC17A4
    • SLC17A5
    • SLC17A6
    • SLC17A7
    • SLC17A8
    • SLC17A9
(18):
  • vesicular monoamine transporter
    • SLC18A1
    • SLC18A2
    • SLC18A3
(19):
  • folate/thiamine transporter
    • SLC19A1
    • SLC19A2
    • SLC19A3
(20):
  • type III Na+-phosphate cotransporter
    • SLC20A1
    • SLC20A2
SLC21–30
(21):
  • Organic anion-transporting polypeptide
    • SLCO1A2
    • SLCO1B1
    • SLCO1B3
    • SLCO1B4
    • SLCO1C1
    • SLCO2A1
    • SLCO2B1
    • SLCO3A1
    • SLCO4A1
    • SLCO4C1
    • SLCO5A1(SLCO6A1)
(22):
  • organic cation/anion/zwitterion transporter
    • SLC22A1
    • SLC22A2
    • SLC22A3
    • SLC22A4
    • SLC22A5
    • SLC22A6
    • SLC22A7
    • SLC22A8
    • SLC22A9
    • SLC22A10
    • SLC22A11
    • SLC22A12
    • SLC22A13
    • SLC22A14
    • SLC22A15
    • SLC22A16
    • SLC22A17
    • SLC22A18
    • SLC22A19
    • SLC22A20
(23):
  • Na+-dependent ascorbic acid transporter
    • SLC23A1
    • SLC23A2
    • SLC23A3
    • SLC23A4
(24):
  • Na+/(Ca2+-K+) exchanger
    • SLC24A1
    • SLC24A2
    • SLC24A3
    • SLC24A4
    • SLC24A5
    • SLC24A6
(25):
  • mitochondrial carrier
    • SLC25A1
    • SLC25A2
    • SLC25A3
    • SLC25A4
    • SLC25A5
    • SLC25A6
    • SLC25A7
    • SLC25A8
    • SLC25A9
    • SLC25A10
    • SLC25A11
    • SLC25A12
    • SLC25A13
    • SLC25A14
    • SLC25A15
    • SLC25A16
    • SLC25A17
    • SLC25A18
    • SLC25A19
    • SLC25A20
    • SLC25A21
    • SLC25A22
    • SLC25A23
    • SLC25A24
    • SLC25A25
    • SLC25A26
    • SLC25A27
    • SLC25A28
    • SLC25A29
    • SLC25A30
    • SLC25A31
    • SLC25A32
    • SLC25A33
    • SLC25A34
    • SLC25A35
    • SLC25A36
    • SLC25A37
    • SLC25A38
    • SLC25A39
    • SLC25A40
    • SLC25A41
    • SLC25A42
    • SLC25A43
    • SLC25A44
    • SLC25A45
    • SLC25A46
(26):
  • multifunctional anion exchanger
    • SLC26A1
    • SLC26A2
    • SLC26A3
    • SLC26A4
    • SLC26A5
    • SLC26A6
    • SLC26A7
    • SLC26A8
    • SLC26A9
    • SLC26A10
    • SLC26A11
(27):
  • fatty acid transport proteins
    • SLC27A1
    • SLC27A2
    • SLC27A3
    • SLC27A4
    • SLC27A5
    • SLC27A6
(28):
  • Na+-coupled nucleoside transport (SLC28A1
    • SLC28A2
    • SLC28A3
(29):
  • facilitative nucleoside transporter
    • SLC29A1
    • SLC29A2
    • SLC29A3
    • SLC29A4
(30):
  • zinc efflux
    • SLC30A1
    • SLC30A2
    • SLC30A3
    • SLC30A4
    • SLC30A5
    • SLC30A6
    • SLC30A7
    • SLC30A8
    • SLC30A9
    • SLC30A10
SLC31–40
(31):
  • copper transporter
    • SLC31A1
(32):
  • Vesicular glutamate transporter 1
    • SLC32A1
(33):
  • Acetyl-CoA transporter
    • SLC33A1
(34):
  • type II Na+-phosphate cotransporter
    • SLC34A1
    • SLC34A2
    • SLC34A3
(35):
  • nucleoside-sugar transporter
    • SLC35A1
    • SLC35A2
    • SLC35A3
    • SLC35A4
    • SLC35A5
    • SLC35B1
    • SLC35B2
    • SLC35B3
    • SLC35B4
    • SLC35C1
    • SLC35C2
    • SLC35D1
    • SLC35D2
    • SLC35D3
    • SLC35E1
    • SLC35E2
    • SLC35E3
    • SLC35E4
(36):
  • proton-coupled amino-acid transporter
    • SLC36A1
    • SLC36A2
    • SLC36A3
    • SLC36A436A2
(37):
  • sugar-phosphate/phosphate exchanger
    • SLC37A1
    • SLC37A2
    • SLC37A3
    • SLC37A4
(38):
  • System A & N, sodium-coupled neutral amino-acid transporter
    • SLC38A1
    • SLC38A2
    • SLC38A3
    • SLC38A4
    • SLC38A5
    • SLC38A6
    • SLC38A10
(39):
  • metal ion transporter
    • SLC39A1
    • SLC39A2
    • SLC39A3
    • SLC39A4
    • SLC39A5
    • SLC39A6
    • SLC39A7
    • SLC39A8
    • SLC39A9
    • SLC39A10
    • SLC39A11
    • SLC39A12
    • SLC39A13
    • SLC39A14
(40):
  • basolateral iron transporter
    • SLC40A1
SLC41–48
(41):
  • Magnesium transporter E
    • SLC41A1
    • SLC41A2
    • SLC41A3
(42):
  • Ammonia transporter
    • RhAG
    • RhBG
    • RhCG
(43):
  • Na+-independent, system-L like amino-acid transporter
    • SLC43A1
    • SLC43A2
    • SLC43A3
(44):
  • Choline-like transporter
    • SLC44A1
    • SLC44A2
    • SLC44A3
    • SLC44A4
    • SLC44A5
(45):
  • Putative sugar transporter
    • SLC45A1
    • SLC45A2
    • SLC54A3
    • SLC45A4
(46):
  • Folate transporter
    • SLC46A1
    • SLC46A2
(47):
  • multidrug and toxin extrusion
    • SLC47A1
    • SLC47A2
(48):
  • Heme transporter
SLCO1–4
  • O1A2
  • O1B1
  • O1B3
  • O2B1
  • O431
  • O4A1
Ion pumps
Symporter, Cotransporter
  • Na+/K+,Cl−
  • Na+/Pi3
  • Na+/Cl−
  • Na+/glucose
  • Na+/I−
  • Cl−/K+
    • 4
    • 5
Antiporter (exchanger)
  • Na+/H+
  • Na+/Ca2+
    • Na+/(Ca2+-K+) - Cl−/HCO−
      3
      (Band 3)
  • Cl−-formate
  • Cl−-oxalate
see also solute carrier disorders


Stub icon

This article on a gene on human chromosome 5 is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://en.wikipedia.org/w/index.php?title=Proton-coupled_amino_acid_transporter_2&oldid=1292453862"
Categories:
  • Genes on human chromosome 5
  • Solute carrier family
  • Human chromosome 5 gene stubs
Hidden categories:
  • Articles with short description
  • Short description matches Wikidata
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id